MBCC: Genomic Profiles
from Cancer Network Podcasts Hosted by Cancer Network
Are genomic profiles refined enough that they should be used routinely to determine which breast cancer patients should receive adjuvant therapy? According to J. Michael Dixon, MD, who will be presenting the contra argument to this question in a debate at the Miami Breast Cancer Conference this week, the answer is: Not yet.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of Cancer Network Podcasts?
This episode is 6 minutes long.
When was this Cancer Network Podcasts episode published?
This episode was published on March 8, 2011.
Can I download this Cancer Network Podcasts episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.